Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastien Campos

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Bioorganic & Medicinal Chemistry Letters|February 2, 2024
Discovery of a novel series of selective macrocyclic PKCTheta inhibitorsStefano Crosignani, Sebastien Campos, Claire Bouix-Peter, et al.
Journal of Medicinal Chemistry|August 27, 2025
Knowledge and Structure-Based Drug Design of 15-PGDH InhibitorsLeela S Dodda, Sebastien Campos, David Ciccone, et al.
Journal of Medicinal Chemistry|September 21, 2020
A Turing Test for Molecular GeneratorsJacob T Bush, Peter Pogany, Stephen D Pickett, et al.
Journal of Medicinal Chemistry|September 10, 2019
Discovery of an Orally Bioavailable Pan αv Integrin Inhibitor for Idiopathic Pulmonary FibrosisNiall A Anderson, Sebastien Campos, Sharon Butler, et al.
Nature Chemical Biology|October 25, 2019
Author Correction: MCT2 mediates concentration-dependent inhibition of glutamine metabolism by MOGLouise Fets, Paul C Driscoll, Fiona Grimm, et al.
Nature Chemical Biology|October 10, 2018
MCT2 mediates concentration-dependent inhibition of glutamine metabolism by MOGLouise Fets, Paul C Driscoll, Fiona Grimm, et al.
Bioorganic & Medicinal Chemistry Letters|April 8, 2009
4-Phenyl-7-azaindoles as potent and selective IKK2 inhibitorsJohn Liddle, Paul Bamborough, Michael D Barker, et al.
Bioorganic & Medicinal Chemistry Letters|July 18, 2012
4-Phenyl-7-azaindoles as potent, selective and bioavailable IKK2 inhibitors demonstrating good in vivo efficacyJohn Liddle, Paul Bamborough, Michael D Barker, et al.
Journal of Medicinal Chemistry|April 29, 2026
Design of Cyclic Vinyl Sulfones as WRN Covalent Inhibitors from Noncovalent BindersJustin A Caravella, Angela V Toms, Nikolay Sitnikov, et al.
Journal of Medicinal Chemistry|September 13, 2021
Discovery of GSK251: A Highly Potent, Highly Selective, Orally Bioavailable Inhibitor of PI3Kδ with a Novel Binding ModeKenneth Down, Augustin Amour, Niall A Anderson, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Bioorganic & Medicinal Chemistry Letters|February 2, 2024
Discovery of a novel series of selective macrocyclic PKCTheta inhibitorsStefano Crosignani, Sebastien Campos, Claire Bouix-Peter, et al.
Journal of Medicinal Chemistry|August 27, 2025
Knowledge and Structure-Based Drug Design of 15-PGDH InhibitorsLeela S Dodda, Sebastien Campos, David Ciccone, et al.
Journal of Medicinal Chemistry|September 21, 2020
A Turing Test for Molecular GeneratorsJacob T Bush, Peter Pogany, Stephen D Pickett, et al.
Journal of Medicinal Chemistry|September 10, 2019
Discovery of an Orally Bioavailable Pan αv Integrin Inhibitor for Idiopathic Pulmonary FibrosisNiall A Anderson, Sebastien Campos, Sharon Butler, et al.
Nature Chemical Biology|October 25, 2019
Author Correction: MCT2 mediates concentration-dependent inhibition of glutamine metabolism by MOGLouise Fets, Paul C Driscoll, Fiona Grimm, et al.
Nature Chemical Biology|October 10, 2018
MCT2 mediates concentration-dependent inhibition of glutamine metabolism by MOGLouise Fets, Paul C Driscoll, Fiona Grimm, et al.
Bioorganic & Medicinal Chemistry Letters|April 8, 2009
4-Phenyl-7-azaindoles as potent and selective IKK2 inhibitorsJohn Liddle, Paul Bamborough, Michael D Barker, et al.
Bioorganic & Medicinal Chemistry Letters|July 18, 2012
4-Phenyl-7-azaindoles as potent, selective and bioavailable IKK2 inhibitors demonstrating good in vivo efficacyJohn Liddle, Paul Bamborough, Michael D Barker, et al.
Journal of Medicinal Chemistry|April 29, 2026
Design of Cyclic Vinyl Sulfones as WRN Covalent Inhibitors from Noncovalent BindersJustin A Caravella, Angela V Toms, Nikolay Sitnikov, et al.
Journal of Medicinal Chemistry|September 13, 2021
Discovery of GSK251: A Highly Potent, Highly Selective, Orally Bioavailable Inhibitor of PI3Kδ with a Novel Binding ModeKenneth Down, Augustin Amour, Niall A Anderson, et al.
Pageof 3